Otsuka Pharmaceutical has shared more detailed data behind its kidney disease drug’s phase 3 win, showing the monoclonal antibody halved patients’ urine protein-to-creatinine ratio (UPCR) levels.

Small amounts of protein can appear in your urine and be OK. Above a certain level, however, may indicate proteinuria, which can be a red flag for kidney disease. Proteins are among the most important ...

Prior studies of uromodulin, the most abundant protein in urine, and kidney disease have focused primarily on urinary uromodulin levels. The current study evaluated associations of serum uromodulin ...

Urine levels of adenine, a metabolite produced in the kidney, are predictive and a causative biomarker of looming progressive kidney failure in patients with diabetes, a finding that could lead to ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

Kidneys are vital organs responsible for filtering waste products, including creatinine, from the blood. Creatinine is a byproduct of muscle metabolism and serves as a key indicator of kidney function ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

With kidney disease on the rise worldwide, we asked the nation's top specialists to share the early signs of the condition.

People with impaired kidney function have higher levels of Alzheimer's biomarkers in their blood, but not an increased risk of dementia, according to a study published in Neurology. The study does not ...

Otsuka Pharmaceutical’s kidney disease drug has hit the primary endpoint of a phase 3 trial by demonstrating in an interim analysis the reduction of patients’ urine protein-to-creatine ratio (UPCR) ...